Company / Revenue per Share
Kura Oncology, Inc. Revenue per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.86
FY2025
5-year range
$0.72 / $0.86
FY2024-FY2025
Trend
+19.0%
vs FY2024
Sector context
#107 of 154
Health Care
What the data says
At $0.86, Kura Oncology, Inc.'s revenue per share ranks #107 of 154 in the Health Care sector.
Based on SEC 10-K filings.
0.86 in FY2025.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#107 of 154 in Health CareTop 69% of 154This company $0.86 Sector average $15.09
▼
-94.3% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 19.0% year-over-year.
- Ranks #107 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.86 | +19.0% |
| FY2024 | $0.72 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026